<DOC>
	<DOCNO>NCT01403688</DOCNO>
	<brief_summary>Fertility drug effect increase hormone level . Higher hormone level infertility treatment may increase breast cancer risk , enough research know sure . Researchers want use method take breast tissue cell woman infertility treatment . The breast tissue cell might show change would indicate increase risk cancer . The method take breast tissue cell call Fine Needle Aspiration ( FNA ) . The purpose study examine change breast tissue , woman high risk breast cancer treat controlled ovarian hyperstimulation .</brief_summary>
	<brief_title>Effects Controlled Ovarian Hyperstimulation ( COH ) With Letrozole Gonadotropin</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Inclusion criterion : 1 . Women must increase risk breast cancer base follow criterion : Age 30 old prior live birth . Mutations associate hereditary cancer ( BRCA1 2 , P53 , PTEN ) Family history breast cancer include one first degree multiple second degree relative History chest radiation age 30 Multiple prior breast biopsy Precancerous condition ( DCIS , LCIS , AH ) Prior history breast ovarian cancer Estimated mammographic breast density &gt; 50 % 2 . Must undergoing infertility treatment University Kansas Controlled Ovarian Hyperstimulation ( COH ) 3 . Must age 2145 ( inclusive ) Day 3 FSH less 12 IU/L , Day 3 E2 less 80 pg/ml Exclusion criterion : 1 . Women 21 45 year old 2 . Day 3 FSH 12 IU/L , Day 3 E2 80 pg/ml 3 . Women meet risk criterion 4 . History hypersensitivity letrozole gonadotropin 5 . Uterine adnexal pathology 6 . Use clomid gonadotropin within 30days letrozole cycle 7 . Any severe chronic disease relevance reproductive function</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>fertility high risk , control ovarian stimulation , breast cancer</keyword>
</DOC>